Seeing Is Believing
Currently out of the existing stock ratings of Dae Gon Ha, 45 are a BUY (71.43%), 18 are a HOLD (28.57%).
Analyst Dae Gon Ha works at STIFEL with a stock forecast success ratio of 38.81% fulfilled within 103.14 days on average.
Dae Gon Ha’s has documented 122 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RARE, Ultragenyx at 16-Jan-2024.
Analyst best performing recommendations are on EDIT (EDITAS MEDICINE).
The best stock recommendation documented was for EDIT (EDITAS MEDICINE) at 5/4/2022. The price target of $15 was fulfilled within 1 day with a profit of $0.81 (5.12%) receiving and performance score of 51.23.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
2
$0.81 (68.07%)
4 months 11 days ago
0/2 (0%)
$0.7 (53.85%)
Buy
2
$0.81 (68.07%)
36
9 months 16 days ago
0/2 (0%)
$0.59 (41.84%)
Hold
2
$0.81 (68.07%)
2
9 months 17 days ago
1/3 (33.33%)
$0.57 (39.86%)
7
Buy
1 years 4 months 22 days ago
0/2 (0%)
$13.44 (140.59%)
Buy
1 years 11 months 12 days ago
0/1 (0%)
$19.05 (212.85%)
Which stock is Dae Gon Ha is most bullish on?
Which stock is Dae Gon Ha is most reserved on?
What Year was the first public recommendation made by Dae Gon Ha?